Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Cardiovascular disease is the leading cause of death in people with type 2 diabetes
Regionally, Asia-Pacific Led the GLP-1 Market
Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
Compounding this plateau, placebo-controlled cardiovascular outcome trials (CVOTs) are increasingly deemed unethical in patients with established CVD, as current standards of care now include agents with proven cardiovascular efficacy, namely GLP-1RA and SGLT-2 inhibitors
US$ 23.78
US$ 28.23
US$ 24.29
US$ 26.18
US$ 22.71
US$ 25.21
US$ 21.74
